Clinical trial
The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on…
NCT00156169 · Sheba Medical Center, Other · Completed
Key facts
| NCT number | NCT00156169 |
|---|---|
| Title | The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients. |
| Official title | The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Low HDL Cholesterol |
| Intervention type | Drug |
| Interventions | Dunaliella |
| Enrollment | 50 |
| Start date | May 1, 2001 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 12, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: